Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care

NACompletedINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Interprofessional RelationsPrimary Health Care/Organization & AdministrationDiabetes Mellitus, Type 2/Prevention & ControlPrimary Prevention/MethodsRisk Reduction BehaviorRandomized Controlled TrialLife Style
Interventions
BEHAVIORAL

Healthy lifestyle prescription

"3 actions for the prevention of DM2 in the clinical setting are recommended:~1. A screening strategy for people with impaired glucose regulation or high risk of developing DM2, with the following recommendations: screening for DM2 within the strategy of opportunistic screening for CV risk factors in population ≥45 years Or ≥30 years in the presence of a previous risk factor (eg, hypertension); Screening for DM2 based on the presence of a BMI ≥25 in the population aged 40-70 years; Or, risk screening for DM2-FINDRISC in a population of 45-70 years.~2. With those identified at high risk, perform a structured program of intensive intervention focused on the prescription of personalized plans on lifestyle modification (low calorie and low fat diet, and at least 150 minutes of physical exercise per week).~3. A follow-up intervention component to maintain the motivation of those interviewed, with more frequent contacts initially, with at least annual review visits."

Trial Locations (1)

Unknown

Primary Care Research Unit of Bizkaia, OSAKIDETZA, Bilbao

All Listed Sponsors
lead

Basque Health Service

OTHER_GOV

NCT03254979 - Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care | Biotech Hunter | Biotech Hunter